deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT00753649

Immunogenicity and Safety of GSK Biologicals' Infanrix Hexa in Infants

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Infanrix Hexa Vaccine in Healthy Infants

Sponsor: GlaxoSmithKline

Conditions Acellular Pertussis Diphtheria Haemophilus Influenzae Type b Hepatitis B Poliomyelitis Tetanus
Interventions Infanrix™ hexa
Updated 10 times since 2017 Last updated: Nov 15, 2019 Started: Sep 23, 2008 Primary completion: Mar 12, 2013 Completion: Mar 12, 2013
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Acellular Pertussis and Diphtheria, this trial is completed. The trial is conducted by GlaxoSmithKline and has accumulated 10 data snapshots since 2008. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotCompleted~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotCompleted~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotCompleted~Jul 2018 – ~Sep 2018 · 2 months · monthly snapshotCompleted~Sep 2018 – ~Dec 2019 · 15 months · monthly snapshotCompleted~Dec 2019 – ~Jan 2021 · 13 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 24 months · monthly snapshotCompleted

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

  5. Dec 2019 — Jan 2021 [monthly]

    Completed PHASE4

▶ Show 5 earlier versions

  1. Sep 2018 — Dec 2019 [monthly]

    Completed PHASE4

  2. Jul 2018 — Sep 2018 [monthly]

    Completed PHASE4

  3. Jun 2018 — Jul 2018 [monthly]

    Completed PHASE4

  4. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations